Table of Contents

company-logo

Berry Genomics Co.,Ltd, a genomics company, develops and commercializes technologies for the life sciences and clinical applications in China. The company offers NGS- based tests for various genetic diseases and cancers from preconception to adulthood; WES test for inherited pathogenic mutations in the GCH1 gene associated with the metabolic disease Dopa-responsive dystonia; CNV-Seq test for indicating translocation at the end of chromosomes 2 and 8; RNA-Seq test to demonstrate the photo-induced protein dimerization of plant cryptochromes; and WGS test for genome wide detection of DNA variants, including SNP, CNV, Indel, and SV. It serves approximately 2,000 hospitals throughout Mainland China, Hong Kong, Macao, and Taiwan. The company serves various organizations and facilities, including hospitals, research institutions, universities, and corporations. Berry Genomics Co.,Ltd has a partnership with Personalis, Inc. The company was founded in 2010 and is headquartered in Beijing, China.

Berry Genomics Dividend Announcement

• Berry Genomics announced a annually dividend of ¥0.14 per ordinary share which will be made payable on . Ex dividend date: 2001-05-25
• Berry Genomics's trailing twelve-month (TTM) dividend yield is -%
• Berry Genomics's payout ratio for the trailing twelve months (TTM) is -4.09%

Berry Genomics Dividend History

Ex-Div dateDividend amountDividend typePay date
2001-05-25¥0.14annually

Berry Genomics Dividend per year

Berry Genomics Dividend Yield

Berry Genomics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Berry Genomics stock? Use our calculator to estimate your expected dividend yield:

Berry Genomics Financial Ratios

P/E ratio-13.95
PEG ratio1.73
P/B ratio2.10
ROE-15.06%
Payout ratio-4.09%
Current ratio2.70
Quick ratio2.37
Cash Ratio0.39

Berry Genomics Dividend FAQ

Does Berry Genomics stock pay dividends?
Berry Genomics does not currently pay dividends to its shareholders.
Has Berry Genomics ever paid a dividend?
No, Berry Genomics has no a history of paying dividends to its shareholders. Berry Genomics is not known for its dividend payments.
Why doesn't Berry Genomics pay dividends?
There are several potential reasons why Berry Genomics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Berry Genomics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Berry Genomics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Berry Genomics a dividend aristocrat?
Berry Genomics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Berry Genomics a dividend king?
Berry Genomics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Berry Genomics a dividend stock?
No, Berry Genomics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Berry Genomics stocks?
To buy Berry Genomics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Berry Genomics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.